Progress in Cancer Immunotherapy

  • Shuren Zhang

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 909)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Shengdian Wang, Mingming Jia
    Pages 1-67
  3. Ronghua Liu, Feifei Luo, Xiaoming Liu, Luman Wang, Jiao Yang, Yuting Deng et al.
    Pages 69-138
  4. Zhenlong Ye, Zhong Li, Huajun Jin, Qijun Qian
    Pages 139-167
  5. Fan Yang, Hao Jin, Jian Wang, Qian Sun, Cihui Yan, Feng Wei et al.
    Pages 169-239
  6. A. Tsun, X. N. Miao, C. M. Wang, D. C. Yu
    Pages 241-283

About this book


This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors.


Antibody Cancer immunotherapy Cellular immunotherapy Oncolytic virus Vaccine

Editors and affiliations

  • Shuren Zhang
    • 1
  1. 1.Dept. of Immunology, Cancer Inst & Hospi Chinese Acad Med & Peking Med CollBeijingChina

Bibliographic information